Federal Register / Vol. 60, No. 32 / Thursday, February 16, 1995 / Notices 9053

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993—Collaboration Agreement

Between Uniphase Corporation and

the Perkin Elmer Corporation

Notice is hereby given that, on

November 15, 1994, pursuant to Section

6(a) of the National Cooperative

Research and Production Act of 1993,

15 U.S.C. 4301 et seq. (‘‘the Act’’),

Uniphase Corporation has filed written

notifications of the formation of a

collaboration on behalf of Uniphase

Corporation and the Perkin Elmer

Corporation simultaneously with the

Attorney General and the Federal Trade

Commission disclosing (1) the identities

of the parties and (2) the nature and

objectives of the venture. The

notifications were filed for the purpose

of invoking the Act’s provisions limiting

the recovery of antitrust plaintiffs to

actual damages under specified

circumstances. Pursuant to Section 6(b)

of the Act, the identities of the parties

are Uniphase Corporation, San Jose, CA;

and the Perkin Elmer Corporation,

Foster City, CA. The general area of

planned activity is the development of

blue laser for DNA diagnostics.

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 95–3914 Filed 2–15–95; 8:45 am]

BILLING CODE 4410–01–M

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated March 18, 1994, and

published in the Federal Register on

March 28, 1994, (59 FR 14426), and by

Notice dated May 6, 1994, and

published in the Federal Register on

May 13, 1994, (59 FR 25126),

Mallinckrodt, Specialty Chemical

Company, Mallinckrodt & Second

Streets, St. Louis, Missouri 63147, made

application to the Drug Enforcement

Administration (DEA) to be registered as

a bulk manufacturer of the basic classes

of controlled substances listed below:

Drug Schedule

Tetrahydrocannabinols (7370) ....... I

Methylphenidate (1724) ................. II

Cocaine (9041) .............................. II

Codeine (9050) .............................. II

Diprenorphine (9058) ..................... II

Etorphine Hydrochloride (9050) ..... II

Dihydrocodeine (9120) .................. II

Ocycodone (9143) ......................... II

Hydromorphone (9150) .................. II

Diphenoxylate (9170) ..................... II

Diphenoxylate (9170) ..................... II

Benzoylecogonine (9180) .............. II

Drug Schedule

Hydrocodone (9193) ...................... II

Levorphanol (9220) ........................ II

Meperidine (9230) .......................... II

Methadone (9250) ......................... II

Methadone-intermediate (9254) .... II

Dextropropoxyphene, bulk (nondosage forms) (9273).II

Morphine (9300) ............................ II

Thebaine (9333) ............................ II

Opium extracts (9610) ................... II

Opium fluid extract (9620) ............. II

Opium tincture (9630) .................... II

Opium powdered (9639) ................ II

Opium granulated (9640) ............... II

Oxymorphone (9652) ..................... II

Alfentanil (9737) ............................. II

Sufentanil (9740) ........................... II

Fentanyl (9801) .............................. II

A registered manufacturer did file a

written request for a hearing with

respect to Methylphenidate. Therefore,

pursuant to Section 303 of the

Comprehensive Drug Abuse Prevention

and Control Act of 1970 and Title 21,

code of Federal Regulations, Section

1301.54(e), Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic classes of controlled

substances listed above is granted with

the exception of Methylphenidate.

Dated: February 6, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–3818 Filed 2–15–95; 8:45 am]

BILLING CODE 4410–09–M

NATIONAL FOUNDATION ON THE

ARTS AND THE HUMANITIES

Notice of Meeting

Pursuant to section 10(a)(2) of the

Federal Advisory Committee Act (Public

Law 92–463), as amended, notice is

hereby given that a meeting of the

Design Advisory Panel (Grants for

Organizations Section) to the National

Council on the Arts will be held on

March 7–10, 1995. The panel will meet

from 8:30 a.m. to 6:30 p.m. on March 7;

from 8:30 a.m. to 7:30 p.m. on March 8;

from 8:30 a.m. to 7:00 p.m. on March 9;

and from 8:30 a.m. to 4:30 p.m. on

March 10 in Room M–07, at the Nancy

Hanks Center, 1100 Pennsylvania

Avenue, N.W., Washington, D.C. 20506.

A portion of this meeting will be open

to the public on March 10, from 2:30

p.m. to 4:30 p.m. for a policy

discussion.

Remaining portions of this meeting

from 8:30 a.m. to 6:30 p.m. on March 7;

from 8:30 a.m. to 7:30 p.m. on March 8;

from 8:30 a.m. to 7:00 p.m. on March 9;

and from 8:30 a.m. to 2:30 p.m. on

March 10 are for the purpose of panel

review, discussion, evaluation, and

recommendation on applications for

financial assistance under the National

Foundation on the Arts and the

Humanities Act of 1965, as amended,

including information given in

confidence to the agency by grant

applicants. In accordance with the

determination of the Chairman of

February 8, 1994, these sessions will be

closed to the public pursuant to

subsection (c) (4), (6) and (9)(B) of

section 552b of Title 5, United States

Code.

Any person may observe meetings, or

portions thereof, of advisory panels

which are open to the public, and may

be permitted to participate in the

panel’s discussions at the discretion of

the Panel chairman and with the

approval of the full-time Federal

employee in attendance.

If you need special accommodations

due to a disability, please contact the

Office of Special Constituencies,

National Endowment for the Arts, 1100

Pennsylvania Avenue, N.W.,

Washington, D.C., 20506, 202/682–5532,

TYY 202/682–5496, at least seven (7)

days prior to the meeting.

Further information with reference to

this meeting can be obtained from Ms.

Yvonne M. Sabine, Committee

Management Officer, National

Endowment for the Arts, Washington,

D.C., 20506, or call 202/682–5433.

Dated: February 13, 1995.

Yvonne M. Sabine,

Director, Office of Council and Panel

Operations, National Endowment for the Arts.

[FR Doc. 95–3938 Filed 2–15–95; 8:45 am]

BILLING CODE 7537–01–M

Notice of Meeting

Pursuant to section 10(a)(2) of the

Federal Advisory Committee Act (Public

Law 92–463), as amended, notice is

hereby given that a meeting of the Folk

and Traditional Arts Advisory Panel

(National Heritage Fellowship Section)

to the National Council on the Arts will

be held on March 8–10, 1995. The panel

will meet from 9:00 a.m. to 10:00 p.m.

on March 8; from 9:00 a.m. to 6:30 p.m.

on March 9; and from 9:00 a.m. to 4:00

p.m. on March 10 in Room 716, at the

Nancy Hanks Center, 1100 Pennsylvania

Avenue N.W., Washington, D.C. 20506.

This meeting is for the purpose of

application evaluation, under the

National Foundation on the Arts and